Sun Pharma Acquires UractivTM Portfolio from Fiterman Pharma in Romania  

May 27, 2022

India

healthysoch

Mumbai/Chandigarh, May 27, 2022: 

Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” including its subsidiaries and/or associate companies), today announced that one of its subsidiaries, S.C. Terapia S.A., Romania has acquired the UractivTM portfolio from Fiterman Pharma in Romania. The UractivTM portfolio comprises food supplements including minerals, vitamins and adjuvants; cosmetics and medical devices used for maintaining urinary tract health.

UractivTM is the No. 1 brand in its category in Romania, trusted by consumers for more than 10 years. The portfolio including 12 SKUs has annualised revenues of approximately US$ 8.7 million*. The products cater to both adults and children. 

 “We are excited to add UractivTM to our consumer healthcare portfolio in Romania. This acquisition is in line with our strategy to further expand our non-prescription product basket in Romania and neighbouring markets,” said Aalok Shanghvi, EVP & Head-Generic R&D, Generic Global BD and Emerging Markets, Sun Pharma. “We have a strong presence in Romania with Terapia being the number one company in the generics and OTC market*. We will leverage our robust marketing and distribution strengths to grow these brands further,” he added.

The acquisition is subject to customary closing conditions and necessary regulatory approvals. Financial terms of the transaction are confidential.

healthysoch

Stay informed with the latest news from HealthySoch. Sign up today for exclusive insights and updates!

We promise we never spam!

Leave a Reply

Your email address will not be published.

Columnists

HealthySoch

Don't Miss

India’s Cumulative COVID-19 Vaccination Coverage crosses the landmark of 47 Cr

“More than 60 Lakh vaccine doses administered in the last

Ebola virus disease – Democratic Republic of the Congo

Disease outbreak news: Update New Delhi, February 29, 2019: The Ebola